TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.” March 9, 2007
